Lifitegrast

Generic Name
Lifitegrast
Brand Names
Xiidra
Drug Type
Small Molecule
Chemical Formula
C29H24Cl2N2O7S
CAS Number
1025967-78-5
Unique Ingredient Identifier
038E5L962W
Background

Lifitegrast is a FDA approved drug for the treatment of keratoconjunctivitis sicca (dry eye syndrome). It is a tetrahydroisoquinoline derivative and lymphocyte function-associated antigen-1 ( LFA-1) antagonist that was discovered through the rational design process. The ophthalmic solution was approved in July, 2016 under the trade name Xiidra. It has shown ...

Indication

适用于治疗干眼病(DED)的症状和体征。

Associated Conditions
Dry Eye Syndrome (DES)
Associated Therapies
-

The Effect of Xiidra on Comfort and Dryness in Symptomatic Contact Lens Wearers

Phase 4
Completed
Conditions
Interventions
First Posted Date
2020-03-05
Last Posted Date
2024-06-27
Lead Sponsor
University of Waterloo
Target Recruit Count
45
Registration Number
NCT04297618
Locations
🇨🇦

Centre for Ocular Research & Education, Waterloo, Ontario, Canada

Clinical Efficacy of Two Topical Dry Eye Drops for Central Corneal Stain Clearing Over 90 Days

First Posted Date
2019-11-21
Last Posted Date
2022-10-20
Lead Sponsor
Toyos Clinic
Target Recruit Count
100
Registration Number
NCT04172961
Locations
🇺🇸

Toyos Clinic, Nashville, Tennessee, United States

A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease

First Posted Date
2019-07-24
Last Posted Date
2023-03-20
Lead Sponsor
Allergan
Target Recruit Count
292
Registration Number
NCT04030962
Locations
🇺🇸

Piedmont Eye Center /ID# 232698, Lynchburg, Virginia, United States

🇺🇸

Cornea and Cataract Consultants of Arizona /ID# 232769, Phoenix, Arizona, United States

🇺🇸

Total Eye Care, PA /ID# 232657, Memphis, Tennessee, United States

and more 8 locations

The Effect Of Lifitegrast On Refractive Accuracy And Symptoms In Dry Eye Patients Undergoing Cataract Surgery

Completed
Conditions
Interventions
First Posted Date
2019-03-07
Last Posted Date
2020-03-19
Lead Sponsor
MDbackline, LLC
Target Recruit Count
103
Registration Number
NCT03866629
Locations
🇺🇸

Harvard Eye Associates, Laguna Hills, California, United States

Lifitegrast 5% Ophthalmic Solution and Contact Lens Dryness

First Posted Date
2018-09-27
Last Posted Date
2018-09-28
Lead Sponsor
EV Clinical Trials
Target Recruit Count
21
Registration Number
NCT03686878
Locations
🇺🇸

Eye & Vision, Richardson, Texas, United States

Effect of Lifitegrast on Dry Eye Disease Signs and Symptoms

Phase 4
Completed
Conditions
Interventions
First Posted Date
2018-03-01
Last Posted Date
2018-03-19
Lead Sponsor
Lifelong Vision Foundation
Target Recruit Count
30
Registration Number
NCT03451396
Locations
🇺🇸

Lifelong Vision Foundation, Chesterfield, Missouri, United States

Use of 5.0% Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease in Contact Lens Wearers

Phase 4
Withdrawn
Conditions
Interventions
First Posted Date
2018-02-13
Last Posted Date
2018-10-25
Lead Sponsor
University of Alabama at Birmingham
Registration Number
NCT03431272
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)

Phase 3
Completed
Conditions
Interventions
First Posted Date
2014-11-06
Last Posted Date
2021-06-11
Lead Sponsor
Shire
Target Recruit Count
711
Registration Number
NCT02284516
Locations
🇺🇸

Chicago Cornea Consultants, Ltd., Hoffman Estates, Illinois, United States

🇺🇸

Jackson Eye, SC, Lake Villa, Illinois, United States

🇺🇸

Lifelong Vision Foundation, Chesterfield, Missouri, United States

and more 38 locations
© Copyright 2024. All Rights Reserved by MedPath